Implantable Cardioverter Defibrillator Market

Implantable Cardioverter Defibrillator Market contains market size and forecasts of Implantable Cardioverter Defibrillator (ICD) in global, including the following market information:

Global Implantable Cardioverter Defibrillator (ICD) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Implantable Cardioverter Defibrillator (ICD) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Implantable Cardioverter Defibrillator (ICD) companies in 2021 (%)

The global Implantable Cardioverter Defibrillator (ICD) market was valued at 6266.5 million in 2021 and is projected to reach US$ 7840.9 million by 2028, at a CAGR of 3.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single Chamber ICD Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Implantable Cardioverter Defibrillator (ICD) include Medtronic, Abbott, Boston Scientific, Philips Healthcare, Zoll Medical, Biotronik Se, Physio-Control International, Cardiac Science and Sorin Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Implantable Cardioverter Defibrillator (ICD) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Implantable Cardioverter Defibrillator (ICD) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Cardioverter Defibrillator (ICD) Market Segment Percentages, by Type, 2021 (%)

Single Chamber ICD

Dual Chamber ICD

Biventricular ICD

Global Implantable Cardioverter Defibrillator (ICD) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Cardioverter Defibrillator (ICD) Market Segment Percentages, by Application, 2021 (%)

Bradycardia

Tachycardia

Heart Failure

Others

Global Implantable Cardioverter Defibrillator (ICD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Cardioverter Defibrillator (ICD) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Implantable Cardioverter Defibrillator (ICD) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Implantable Cardioverter Defibrillator (ICD) revenues share in global market, 2021 (%)

Key companies Implantable Cardioverter Defibrillator (ICD) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Implantable Cardioverter Defibrillator (ICD) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

Abbott

Boston Scientific

Philips Healthcare

Zoll Medical

Biotronik Se

Physio-Control International

Cardiac Science

Sorin Group

Nihon Kohden

Shree Pacetronix Ltd.

EBR Systems

MEDICO S.p.A.